Federal Data HubHRSA 340B · JSON

Prevention Point Philadelphia

Main · 340B ID STD19134

ParticipatingSTD

Prevention Point Philadelphia is a STD enrolled in the federal 340B Drug Pricing Program in Philadelphia, PA. The program lets qualifying providers buy outpatient drugs at deep federal discounts. This entity reports 20 contract-pharmacy arrangement(s) (3 currently active) — the third-party pharmacies that dispense its 340B-discounted drugs.

Contract pharmacies (20)

PharmacyLocationBeginTerminatedPharmacy ID
CAREMARK FLORIDA SPECIALTY PHARMACY LLCTAMPA, FL2020-10-012024-07-0141487
CAREMARK ILLINOIS SPECIALTY PHARMACY, LLMOUNT PROSPECT, IL2020-10-012024-07-0159113
CAREMARK KANSAS SPECIALTY PHARMACYLENEXA, KS2020-10-012024-07-0162899
CAREMARK MASSACHUSETTS SPECIALTY PHARMACMILFORD, MA2020-10-012024-07-0113653
CAREMARK MICHIGAN SPECIALTY PHARMACY, LLTROY, MI2020-10-012024-07-0153118
CAREMARK NEW JERSEY SPECIALTY PHCY, LLCFAIRFIELD, NJ2020-10-012024-07-0116293
CAREMARK NORTH CAROLINA SPECIALTY PHARMARALEIGH, NC2020-10-012024-07-0131787
CAREMARK PUERTO RICO SPECIALTY PHARMACY,CAROLINA, PR2020-10-012021-03-3112961
CAREMARK TENNESSEE SPECIALTY PHARMACY, LBARTLETT, TN2020-10-012024-07-0145962
CAREMARK, L.L.C.REDLANDS, CA2020-10-012024-07-01612
CAREMARK, L.L.C.LAS VEGAS, NV2020-10-012024-07-01125644
CVS/SPECIALTY OR CARELONRX SPECIALTY PHAFLOWER MOUND, TX2020-10-012024-07-01111796
PELHAM PHARMACYPHILADELPHIA, PA2022-10-0125640
PROCARE PHARMACY DIRECT, L.L.C.MONROEVILLE, PA2020-10-012024-07-012289
PROCARE PHARMACY, L.L.C.BIRMINGHAM, AL2020-10-012024-07-0143566
PROCARE PHARMACY, L.L.C.HONOLULU, HI2020-10-012024-07-011280
PROCARE PHARMACY, L.L.C.PHILADELPHIA, PA2020-10-012024-07-0125550
PROCARE PHARMACY, L.L.C.COLUMBIA, SC2020-10-012024-07-0134053
SUNRAY DRUGS KENSINGTON & ALLEGHENYPHILADELPHIA, PA2020-01-01106724
SUNRAY DRUGS SPECIALTYPHILADELPHIA, PA2019-10-01106013

Click a Pharmacy ID to see every other 340B entity using that same pharmacy.

About this data

The 340B Drug Pricing Program (Public Health Service Act §340B) requires drug manufacturers to sell outpatient drugs to enrolled "covered entities" — disproportionate-share hospitals, federally qualified health centers, and specialized clinics — at significant discounts. Covered entities increasingly contract with third-party "contract pharmacies" to dispense these drugs, a practice that has grown explosively and drawn scrutiny over how the discounts are used. This page mirrors HRSA's Office of Pharmacy Affairs (OPAIS) public registry.

Source: HRSA OPAIS. License: CC0 1.0. Snapshot 2026-06-25.